{
  "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310",
  "docSlug": "d4b095284b050177fedb9bcc804883cf",
  "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides",
  "authorId": "albireo-pharma",
  "authorName": "Albireo Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 1,
  "pageCount": 18,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "cover",
  "function": "front_matter",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/hX_B5EGuW323xVHDGXuFyZYtjjWujm4LruyrDX5jHew/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLmpwZw",
  "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/1",
  "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310",
  "deckJsonHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310.json",
  "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-1",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.415,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "For Media & Investors Only ©2022 Albireo Pharma, Inc. All rights reserved",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98385857-5d98-4052-95b9-2aa20cc8b884",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.76,
        "y": 0.84
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31f1e0a0-4bc9-4361-87b9-1c52305484e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 1,
        "w": 1,
        "x": 0,
        "y": 0
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "853c7b6d-62d1-495c-a5a7-ddc5662f3c13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.435,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "ASSERT: Phase 3 study evaluating the safety and efficacy of Bylvay® (odevixibat) in patients with Alagille syndrome",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49e937bf-102a-4fda-8195-aaa134f758b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.81,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "October 2022 (Nasdaq: ALBO)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8fc179c-3504-4db6-978c-cd8053e28b86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.3,
        "x": 0.63,
        "y": 0.515
      },
      "kind": "title",
      "text": "ASSERT Topline Data Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79006dbf-a937-478e-8fd7-eed2c8f43309",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Slide recipe: Cover",
      "slug": "cover-slide",
      "agent": "designer",
      "layer": "slide",
      "matchId": "1cb16018-821b-4cc8-9adc-835c43ad1d1c",
      "evidence": "ASSERT Topline Data Results",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/kvW1aChOSrkqOf1ceNrCQs1vth2kkYsUnXX0KNci96g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLnBuZw",
  "thumbSrc": "https://imgproxy.kitesheet.com/-j8bFTsrtoW_QDBAEKYtvLnYuWEhKTRTvBp2PBitUfU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLmpwZw",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/VBBYlHYqyhFQTbM8yy884tGjeE8c9Bdv_13XElbIXB8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLnBuZw"
}